Study Summary
Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory to be changed (modified) to become 19-28z/IL-18, the CAR T-cell therapy that participants will receive during the study. Making the participants' study therapy will take about 2-4 weeks.
Want to learn more about this trial?
Request More InfoInterventions
19-28z/IL-18 CAR T cellsBIOLOGICAL
19-28z/IL-18 CAR T cells are an investigational new drug (IND) for the treatment of R/R B-ALL
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | United States |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | New Jersey | United States |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | New Jersey | United States |
| Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities) | Commack | New York | United States |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | United States |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | United States |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | New York | United States |